from News-Economic Times https://ift.tt/2G0ZGA4
Home »
News-Economic Times
» Eli Lilly antibody drug fails in a COVID-19 study; others go on
Eli Lilly antibody drug fails in a COVID-19 study; others go on
from News-Economic Times https://ift.tt/2G0ZGA4
Related Posts:
Fight for Senate control awaits in Georgia after Biden's win, likely to stretch till JanuarySo far, the tally for the next Senate is 48 Republicans and 48 Democrats after Tuesday's election. Two seats in Georgia are headed to runoffs on Jan. 5. And seats in North Carolina and Alaska are still too early to call. fro… Read More
Awarding of NH projects doubles despite pandemicThe pace of award of national highway (NH) projects has almost doubled in the past seven months compared to last year despite the Covid pandemic situation. Overall construction is nearly 90% of last year and road transport … Read More
COVID-19 cases in India breach 85-lakh markThe case fatality rate stands at 1.48 per cent. The number of active cases of COVID-19 remained below 6 lakh for the tenth consecutive day. There are 5,12,665 active cases of coronavirus infection in the country as on date wh… Read More
How Biden navigated pandemic politics to win the race to the highest American officeBiden's decision to stop campaigning for days was without precedent in modern American politics. Barack Obama and John McCain returned to Washington in the final weeks of the 2008 campaign to respond to that year's financial … Read More
View: Trump's politics of grievance will outlast him. America’s age of anger is just getting startedThere is little respite from clownish demagoguery once a long-standing political order loses credibility and legitimacy among a significantly large proportion of the population. That fatal conjuncture was achieved imperceptib… Read More
0 Comments:
Post a Comment